CD34 and neoplasm: To remove the effect of contaminating non-tumor cells, the analysis was limited to 16 samples with SF3B1K700E allele that was expressed in >90% of the cells as estimated from the variant allele frequencies in RNA: nine bone marrow CD34+ cell samples, four BMMNC samples, and three HEK293T cell lines with SF3B1K700E mutation.